Your browser doesn't support javascript.
loading
Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial.
Mi, Weifeng; Yang, Fude; Li, Huafang; Xu, Xiufeng; Li, Lehua; Tan, Qingrong; Wang, Guoqiang; Zhang, Kerang; Tian, Feng; Luo, Jiong; Xia, Jielai; Yuan, Kai; Lu, Lin; Deng, Jiahui; Tian, Jingwei; Zhang, Hongyan.
Afiliação
  • Mi W; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
  • Yang F; Beijing Huilongguan Hospital, Beijing, China.
  • Li H; Shanghai Mental Health Center, Shanghai, China.
  • Xu X; First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Li L; Second Xiangya Hospital of Central South University, Changsha, China.
  • Tan Q; First Affiliated Hospital of the Fourth Military Medical University (Air Force Medical University), Xi'an, China.
  • Wang G; Wuxi Mental Health Center, Wuxi, China.
  • Zhang K; First Hospital of Shanxi Medical University, Taiyuan, China.
  • Tian F; Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Luo J; Beijing Anding Hospital of Capital Medical University, Beijing, China.
  • Xia J; Fourth Military Medical University of Chinese People's Liberation Army, Statistical Analysis Teaching and Research Section, Xi'an, China.
  • Yuan K; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
  • Lu L; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
  • Deng J; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
  • Tian J; Yantai University, Yantai, China.
  • Zhang H; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Int J Neuropsychopharmacol ; 25(3): 252-260, 2022 03 17.
Article em En | MEDLINE | ID: mdl-34747448
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Idioma: En Ano de publicação: 2022 Tipo de documento: Article